| Dr Alexander L Grigalunas, MD | |
|
502 S M St, Tacoma, WA 98405-3728 | |
| (253) 301-4953 | |
| (253) 301-4845 |
| Full Name | Dr Alexander L Grigalunas |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 12 Years |
| Location | 502 S M St, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013279298 | NPI | - | NPPES |
| 2081786 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD60690632 (Washington) | Primary |
| 207WX0009X | Ophthalmology - Glaucoma Specialist | MD60690632 (Washington) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.
A team from the University of California, Berkeley, have found in a study that pregnant women are more likely to miscarry male fetuses than females fetuses during times of stress.
The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.
More than 50 companies are actively developing new products to diagnose tuberculosis (TB), a disease that killed 1.5 million people in 2013, but many countries still rely on older sputum-based methods, according to a report published by UNITAID.
The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMD) are funding new cross-campus research projects as part of a new joint program that seeks to solve big health care challenges through joint research that draws on the institutions world leading expertise in medicine and artificial intelligence.
› Verified 6 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.
A team from the University of California, Berkeley, have found in a study that pregnant women are more likely to miscarry male fetuses than females fetuses during times of stress.
The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.
More than 50 companies are actively developing new products to diagnose tuberculosis (TB), a disease that killed 1.5 million people in 2013, but many countries still rely on older sputum-based methods, according to a report published by UNITAID.
The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMD) are funding new cross-campus research projects as part of a new joint program that seeks to solve big health care challenges through joint research that draws on the institutions world leading expertise in medicine and artificial intelligence.
› Verified 6 days ago
| Entity Name | Evergreen Eye Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700959293 PECOS PAC ID: 3173410057 Enrollment ID: O20040304001193 |
News Archive
The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.
A team from the University of California, Berkeley, have found in a study that pregnant women are more likely to miscarry male fetuses than females fetuses during times of stress.
The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.
More than 50 companies are actively developing new products to diagnose tuberculosis (TB), a disease that killed 1.5 million people in 2013, but many countries still rely on older sputum-based methods, according to a report published by UNITAID.
The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMD) are funding new cross-campus research projects as part of a new joint program that seeks to solve big health care challenges through joint research that draws on the institutions world leading expertise in medicine and artificial intelligence.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander L Grigalunas, MD 310 15th Ave E, Seattle, WA 98112-5103 Ph: (206) 326-3867 | Dr Alexander L Grigalunas, MD 502 S M St, Tacoma, WA 98405-3728 Ph: (253) 301-4953 |
News Archive
The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults, bringing these patients their first pharmaceutical innovation in over 50 years.
A team from the University of California, Berkeley, have found in a study that pregnant women are more likely to miscarry male fetuses than females fetuses during times of stress.
The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.
More than 50 companies are actively developing new products to diagnose tuberculosis (TB), a disease that killed 1.5 million people in 2013, but many countries still rely on older sputum-based methods, according to a report published by UNITAID.
The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMD) are funding new cross-campus research projects as part of a new joint program that seeks to solve big health care challenges through joint research that draws on the institutions world leading expertise in medicine and artificial intelligence.
› Verified 6 days ago
Elizabeth Ann Hansen, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Madigan Army Medical Ctr, Attn Mchj-sou (col Hansen), Tacoma, WA 98431 Phone: 253-968-1760 | |
Dr. Joshua Robert Roe, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1670 | |
John T. Heffernan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 502 S M St, Tacoma, WA 98405 Phone: 206-212-2100 Fax: 206-212-2194 | |
Andrew B Kopstein, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 502 S M St, Tacoma, WA 98405 Phone: 253-301-4953 Fax: 253-301-4845 | |
Dr. Michael Scott Seward, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2915 S Alder St, Tacoma, WA 98409 Phone: 125-347-3027 | |
Hoon C Jung, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3602 S 19th St, Tacoma, WA 98405 Phone: 253-759-5555 Fax: 253-830-5420 |